Needham downgraded ShockWave Medical (SWAV) to Hold from Buy after the company entered into an agreement under which Johnson & Johnson (JNJ) will acquire it for $335 per share in cash.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Odyssey Therapeutics enters into a collaboration with Jannsen Pharmaceutica
- Paging Dr. Nvidia (NASDAQ:NVDA): AI and Healthcare
- J&J to pay $75M to settle $6B baby powder lawsuit, Bloomberg reports
- J&J to pay $75M to settle Mississipi talc lawsuit, Bloomberg says
- Judge gives J&J new chance to contest evidence on talc products, Reuters says
